Diabetes

Study finds a two-fold higher risk of developing nAMD in older patients with diabetes taking a GLP-1 RA compared to similar patients with diabetes not exposed to GLP1 RAs. 

Incorporates new evidence with the aim to prevent end-stage kidney disease in most people with diabetes by adopting health behaviours and use of pharmacologic therapies. 

Meta-analysis evaluates psychiatric, cognitive and quality-of-life outcomes with glucagon-like peptide-1 receptor agonist treatment.

Women who slept less than six hours combined with regular snoring had the highest risk of diabetes progression, study finds.

A team of Iranian researchers unveils the first meta-analysis on the dose-response association of aerobic exercise with weight, waist circumference and body fat in overweight and obese people.

Get the info you need on this new dosage form, part of our drug news roundup for April.

Patients using icodec tend to have a higher incidence of hypoglycemic events compared to glargine or degludec, especially on days 2–4 of the weekly dosing cycle.

Research suggests bioactive compounds in chocolate may help reduce the risk of type 2 diabetes. But not all chocolate offers the same benefits.